| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.34 | 7e-22 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-12 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.26 | 8e-11 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-10 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-09 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-08 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |